US2019048052A1PendingUtilityA1
Anti-microbial peptides and coatings
Est. expiryAug 18, 2036(~10 yrs left)· nominal 20-yr term from priority
A61K 45/06C07K 7/06C07K 14/4723A61K 38/17A61K 38/00C12N 15/09C07K 7/08
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Antimicrobial peptides and methods of use are provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated peptide comprising the amino acid sequence WWWX 1 X 2 X 3 X 4 W (SEQ ID NO: 16), wherein X 1 -X 4 are any amino acid.
2 . The isolated peptide of claim 1 , wherein X 1 is Ile, Leu, or Val.
3 . The isolated peptide of claim 1 , wherein X 2 and X 3 are Arg, Lys, or His.
4 . The isolated peptide of claim 1 , wherein X 4 is Ile, Arg, or Lys.
5 . The isolated peptide of claim 1 , wherein said peptide comprises at least one D-amino acid.
6 . The isolated peptide of claim 1 , wherein all of the amino acids are D-amino acids.
7 . The isolated peptide of claim 1 , wherein said peptide comprises at least one modification selected from the group consisting of amidation and acetylation.
8 . The isolated peptide of claim 1 , wherein said peptide is less than 12 amino acids in length.
9 . A composition comprising at least one peptide of claim 1 and at least one pharmaceutically acceptable carrier.
10 . The composition of claim 8 , further comprising at least one antibiotic.
11 . A method for inhibiting a microbial infection in a subject in need thereof, said method comprising administering to said subject at least one peptide of claim 1 .
12 . The method of claim 11 , further comprising the administration of at least one additional antibiotic.
13 . The method of claim 11 , wherein said microbial infection is a staphylococcal infection.
14 . The method of claim 11 , wherein said microbial infection is a methicillin-resistant Staphylococcus aureus (MRSA) infection.
15 . The method of claim 11 , wherein said antimicrobial peptide is covalently attached to the surface of a medical device or implant
16 . A medical device or implant comprising at least one antimicrobial peptide of claim 1 covalently attached to the surface of the medical device or implant.
17 . The isolated peptide of claim 1 , wherein said peptide is less than 25 amino acids in length.
18 . The isolated peptide of claim 1 , wherein said peptide is antibacterial.
19 . The isolated peptide of claim 1 , wherein said peptide is less than 10 amino acids in length.
20 . The isolated peptide of claim 1 consisting the amino acid sequence WWWX 1 X 2 X 3 X 4 W (SEQ ID NO: 16), wherein X 1 -X 4 are any amino acid.Join the waitlist — get patent alerts
Track US2019048052A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.